The Centers for Medicare & Medicaid Services, otherwise known as Medicare, which is headquartered in Baltimore in the United States. Proteomics International (ASX: PIQ) has notched up a major win in the US, with the nation’s powerful Medicare system setting a reimbursement price of US$390.75 (A$604) for the company’s groundbreaking PromarkerD predictive kidney disease blood test. The Centers for Medicare & Medicaid Services (CMS) ruling effectively hands the medical technolo

The results of Proteomics OxiDx blood testing trials are being presented today in Sydney at the Australian Physiological Society (AuPS) Annual Scientific Meeting. Proteomics International (ASX: PIQ) has delivered another strong data set from its precision diagnostics pipeline. The company has revealed that its unique, majority-owned “OxiDx” blood test for Thoroughbred racehorses shows a strong correlation between horses racing with low levels of oxidative stress and those th

Proteomics International Laboratories has received a $2.16m R&D rebate for costs incurred in the previous financial year on the research of proteins as a marker for diagnostic tests. Medical diagnostics pioneer Proteomics International Laboratories (ASX: PIQ) has filled its pockets with a further $2.2 million in cash through Australia’s research and development (R&D) rebate scheme. The company’s technology sits at the forefront of proteomics - protein-based precision medicin

Proteomics International is a medical technology company at the forefront of precision diagnostics and bio-analytical services that is making giant strides in early detection of serious diseases. After going commercial in August and September with two medical diagnostic products, Proteomics International (ASX: PIQ) is now set to see a growing pipeline of revenues. The September 2025 quarter saw the company make significant progress in commercialisation, clinical certificatio

Proteomics International Laboratories has inked an expanded research deal with the University of Melbourne and Royal Women’s Hospital to pinpoint its attack on early endometriosis identification.

Proteomics International Laboratories has achieved certification for its Perth lab, which will provide world-class test results for...

Trials of Proteomics International’s PromarkerEso blood test have delivered a near-perfect score for the detection of throat cancer...

Proteomics International Laboratories’ innovative OxiDx muscle stress test could soon be used to monitor muscle damage in thoroughbred...

Proteomics International’s PromarkerD diabetes-related blood test has just been assigned an American Medical Association billing code,...

Proteomics research scientist Martin Mead adjusts a mass spectrometer column used for its proteomics diagnostics research in the...

Proteomics International has patented PromarkerEndo, its breakthrough early diagnostic test for endometriosis, in Japan. In a milestone...

Proteomics International Laboratories has officially launched the US rollout of its PromarkerD kidney diagnostic test at a conference in...

Newly published results from Proteomics International have revealed its PromarkerEso blood test can detect early oesophageal cancer with...

Proteomics International groundbreaking, simple endometriosis blood test could revolutionise healthcare for the disease. ASX-listed...

A majority owned subsidiary of Proteomics International has picked up a Chinese patent for a finger-prick test that tracks oxidative muscle stress linked to most sports and horse racing injuries.

Proteomics International Laboratories managing director Dr Richard Lipscombe. The company has locked in $4.5 million to fast-track the...

Proteomics International Laboratories ls launching its PromarkerEso esophageal cancer test globally, backed by a top-tier clinical board...

A Proteomics International Laboratories subsidiary has received an Australian patent for its finger-prick blood test that tracks muscle...

Assay plates on an automated platform using PromarkerD to test for the early signs of chronic kidney disease in type 2 diabetes patients....

Results from a trial of Proteomics International Laboratories’ PromarkerD blood test for the detection of chronic kidney disease have...